By Dennis Ford, Founder & CEO, LSN
LSN has been beseeched by many scientist-entrepreneurs and investors asking us to bring the Redefining Early Stage Investments (RESI) Conference to California to coincide with the well-known JP Morgan Healthcare Conference. Many CEOs of private biotech and medtech startups attend the JP Morgan event hoping to meet strategic pharma business development folks as well as investors who may be contemplating funding early stage development as part of a buy low, sell high strategy. Mid-level private equity, virtual pharma, and corporate venture investors are all in the mix.
Hosting our event to coincide with the JP Morgan conference makes good sense, as RESI is strictly focused on these same two groups: private early stage biotech and medtech scientist-entrepreneurs, who are primarily translational scientists and newly minted entrepreneurs developing devices or drug treatments, and early stage investors who are seeking emerging opportunities.
This is why at our third RESI Conference, we announced that our next event will be in San Francisco on January 13, 2015. Bringing RESI to San Francisco will be a great opportunity for all the early stage players to connect and form some dynamic relationships. California, here we come!
Next Phase Newsletter 
Leave a Reply